TMO Financial Facts
Total revenues: 4.49BIncome from Continuing Operations: 473.5M
See Full Income Statement
Total current liabilities: 5.26B
Goodwill: 21.58B
See Full Balance Sheet
Thermo Fisher Scientific, Inc. (TMO) Earnings
|
Expand Research on TMO
| Next EPS Date | 7/23/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +2.6% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +1.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/29/26  |
Q126 | N/A | $5.27 | N/A | N/A | $10.87B | N/A | N/A | N/A | ||
| 1/29/26 | Q425 | $6.57 | $6.45 | +$0.12 | $12.21B | $11.89B | N/A |  | | Details | |
| 10/22/25 | Q325 | $5.79 | $5.50 | +$0.29 | $11.12B | $10.91B | N/A | | | Details | |
| 7/23/25 | Q225 | $5.36 | $5.23 | +$0.13 | $10.85B | $10.68B | N/A | | | Details | |
| 4/23/25 | Q125 | $5.15 | $5.11 | +$0.04 | $10.36B | $10.23B | N/A | | | Details | |
| 1/30/25 | Q424 | $6.10 | $5.95 | +$0.15 | $11.4B | $11.29B | N/A | | | Details | |
| 10/23/24 | Q324 | $5.28 | $5.25 | +$0.03 | $10.6B | $10.63B | = | | | Details | |
| 7/24/24 | Q224 | $5.37 | $5.12 | +$0.25 | $10.54B | $10.5B | = | | | Details |
